Hcr Wealth Advisors Editas Medicine, Inc. Transaction History
Hcr Wealth Advisors
- $658 Million
- Q1 2024
A detailed history of Hcr Wealth Advisors transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Hcr Wealth Advisors holds 17,000 shares of EDIT stock, worth $77,180. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,000
Previous 22,000
22.73%
Holding current value
$77,180
Previous $222,000
43.24%
% of portfolio
0.02%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding EDIT
# of Institutions
243Shares Held
69.3MCall Options Held
564KPut Options Held
428K-
State Street Corp Boston, MA8.76MShares$39.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.56MShares$38.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.83MShares$35.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.53MShares$25.1 Million1.35% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.61MShares$11.8 Million0.01% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $312M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...